
Debiopharm, Oncodesign Agree to Use Non-Invasive Technology for Preclinical Research
The Switzerland-based biopharmaceutical company Debiopharm Research & Manufacturing has announced a license agreement with Oncodesign Services, of Dijon, France, for the use of a technology known as AbYlink for preclinical services (1). In a press …